Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Discovery and Validation of Breast Cancer Predisposing Genes in French Canadian Founder Populations

EF 2017-18

Résumé
Breast cancer is the leading cancer diagnosis in women, and has been for many years. A new diagnosis of the cancer occurs every 20 minutes in Canadians alone, and there is a 1 in 30 chance that a Canadian woman will die of breast cancer during her lifetime. One of the strongest risk factors of breast cancer is having a family background, in which case a person can be more susceptible to developing a tumour simply due to the genes they have acquired from their mother or father. Well-known examples of this phenomenon are the BRCA1 and BRCA2 genes: If a person carries a mutation in one of these two genes, it greatly increases that person’s chance to develop breast cancer and this mutation can be passed down over generations. My project aims to identify more of the ‘susceptibility’ genes that can increase a person’s chance of developing breast cancer. Previous research has found that certain susceptibility gene mutations are more prevalent in the French-Canadian population of Quebec. By focusing on this population, I have a higher chance at finding very rare mutations that can predispose a patient to breast cancer. The overall goal of my project is to add to local screening strategies that are used in today’s cancer clinics to identify women and men who have a high risk for breast cancer. In doing so, more high-risk patients in Quebec can be given earlier diagnosis and take targeted preventative measures against the complex disease, and non-carrier relatives can be spared unnecessary aggressive preventive measures such as prophylactic mastectomy.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
397662
Name
Behl Supriya
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Discovery and Validation of Breast Cancer Predisposing Genes in French Canadian Founder Populations
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Breast Cancer; Cancer Surveillance; Cancer Susceptibility; Cancers Predisposition; Etiology; Founder Populations; Genetics; Hereditary Cancers; Oncology; Tumor-Normal Sequencing
Abstract
Breast cancer is the leading cancer diagnosis in women, and has been for many years. A new diagnosis of the cancer occurs every 20 minutes in Canadians alone, and there is a 1 in 30 chance that a Canadian woman will die of breast cancer during her lifetime. One of the strongest risk factors of breast cancer is having a family background, in which case a person can be more susceptible to developing a tumour simply due to the genes they have acquired from their mother or father. Well-known examples of this phenomenon are the BRCA1 and BRCA2 genes: If a person carries a mutation in one of these two genes, it greatly increases that person’s chance to develop breast cancer and this mutation can be passed down over generations. My project aims to identify more of the ‘susceptibility’ genes that can increase a person’s chance of developing breast cancer. Previous research has found that certain susceptibility gene mutations are more prevalent in the French-Canadian population of Quebec. By focusing on this population, I have a higher chance at finding very rare mutations that can predispose a patient to breast cancer. The overall goal of my project is to add to local screening strategies that are used in today’s cancer clinics to identify women and men who have a high risk for breast cancer. In doing so, more high-risk patients in Quebec can be given earlier diagnosis and take targeted preventative measures against the complex disease, and non-carrier relatives can be spared unnecessary aggressive preventive measures such as prophylactic mastectomy.
Competitiondate
201712
Approvedterm2
1 yr 0 mth
Pinamesdelim
Behl, Supriya
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~